Globus Medical, Inc. (GMED)

Market Cap	6.82B
Revenue (ttm)	1.57B
Net Income (ttm)	122.87M
Shares Out	135.37M
EPS (ttm)	1.07
PE Ratio	47.06
Forward PE	18.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,014,496
Open	51.03
Previous Close	50.75
Day's Range	49.94 - 51.56
52-Week Range	43.39 - 62.88
Beta	1.10
Analysts	Buy
Price Target	66.33 (+31.74%)
Earnings Date	May 7, 2024

About GMED

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, tot...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 3, 2012
• Employees: 5,000
• Stock Exchange: NYSE
• Ticker Symbol: GMED

Financial Performance

In 2023, Globus Medical's revenue was $1.57 billion, an increase of 53.34% compared to the previous year's $1.02 billion. Earnings were $122.87 million, a decrease of -35.39%.

Analyst Forecast

According to 10 analysts, the average rating for GMED stock is "Buy." The 12-month stock price forecast is $66.33, which is an increase of 31.74% from the latest price.

Price Target

$66.33

(31.74% upside)

Analyst Consensus: Buy